Depressive Disorders - Turkey

Turkey

Revenue in the Depressive Disorders market is projected to reach US$126.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 0.02%, resulting in a market volume of US$126.40m by 2028.
In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
In relation to total population figures, per person revenues of US$28.35 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The Depressive Disorders market in Turkey is experiencing significant growth and development.

Customer preferences: In recent years, there has been an increasing awareness and understanding of mental health issues in Turkey. As a result, more people are seeking help and treatment for depressive disorders. This shift in customer preferences is driven by a growing recognition of the importance of mental well-being and a desire for improved quality of life.

Trends in the market: One of the key trends in the Depressive Disorders market in Turkey is the rising demand for pharmaceutical treatments. Antidepressant medications are becoming more widely prescribed and used as a primary treatment option for depressive disorders. This trend is driven by the effectiveness of these medications in managing symptoms and improving overall mental health. Additionally, there is a growing acceptance and destigmatization of mental health issues, which has led to increased willingness to seek medical help and adhere to treatment plans.Another trend in the market is the increasing availability and accessibility of mental health services. Turkey has seen a significant expansion in the number of mental health clinics and professionals, making it easier for individuals to access care. This trend is supported by the government's efforts to improve mental health services and increase funding for mental health initiatives.

Local special circumstances: Turkey has a relatively high prevalence of depressive disorders compared to other countries. This may be attributed to a combination of cultural, social, and economic factors. The rapid urbanization and modernization of Turkish society have led to increased levels of stress and pressure, which can contribute to the development of depressive disorders. Additionally, the stigma surrounding mental health issues in Turkey has historically been a barrier to seeking help. However, recent efforts to raise awareness and reduce stigma have helped to overcome this barrier and encourage more people to seek treatment.

Underlying macroeconomic factors: Turkey's strong economic growth and increasing healthcare expenditure have also contributed to the development of the Depressive Disorders market. As the economy has grown, individuals have more disposable income to spend on healthcare services, including mental health treatments. Furthermore, the government's commitment to improving healthcare infrastructure and services has created a favorable environment for the growth of the Depressive Disorders market.In conclusion, the Depressive Disorders market in Turkey is experiencing significant growth and development due to changing customer preferences, increasing availability of mental health services, local special circumstances, and underlying macroeconomic factors. This presents opportunities for pharmaceutical companies and healthcare providers to cater to the growing demand for mental health treatments in the country.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.